US HB6749 | 2023-2024 | 118th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 48-10)
Status: Introduced on December 13 2023 - 25% progression
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 13 2023 - 25% progression
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Director of the National Institutes of Health to evaluate the results and status of completed and ongoing research related to menopause, perimenopause, or mid-life women's health, to conduct and support additional such research, and for other purposes.
Title
Menopause Research and Equity Act of 2023
Sponsors
History
Date | Chamber | Action |
---|---|---|
2023-12-15 | House | Referred to the Subcommittee on Health. |
2023-12-13 | House | Referred to the House Committee on Energy and Commerce. |
2023-12-13 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/6749/all-info |
Text | https://www.congress.gov/118/bills/hr6749/BILLS-118hr6749ih.pdf |